(3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one

C19H25N5O3 — CID 125159069

IUPAC(3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one
SMILESCc1cc2n(n1)CCN(C(=O)C[C@H]1C(=O)NCCN1Cc1ccc(C)o1)C2
InChIInChI=1S/C19H25N5O3/c1-13-9-15-11-23(7-8-24(15)21-13)18(25)10-17-19(26)20-5-6-22(17)12-16-4-3-14(2)27-16/h3-4,9,17H,5-8,10-12H2,1-2H3,(H,20,26)/t17-/m0/s1
InChIKeyCXSCJVVVIOCJAL-KRWDZBQOSA-N
MW371.44 g/mol
LogP0.83
Rot. Bonds4

About (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one

(3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one (PubChem CID 125159069) has the molecular formula C19H25N5O3 and a molecular weight of 371.44 g/mol. Its IUPAC name is (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one.

Molecular Properties

Compound Name(3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one
PubChem CID125159069
Molecular FormulaC19H25N5O3
Molecular Weight371.44 g/mol
Exact Mass371.20
IUPAC Name(3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one
SMILESCc1cc2n(n1)CCN(C(=O)C[C@H]1C(=O)NCCN1Cc1ccc(C)o1)C2
InChIInChI=1S/C19H25N5O3/c1-13-9-15-11-23(7-8-24(15)21-13)18(25)10-17-19(26)20-5-6-22(17)12-16-4-3-14(2)27-16/h3-4,9,17H,5-8,10-12H2,1-2H3,(H,20,26)/t17-/m0/s1
InChIKeyCXSCJVVVIOCJAL-KRWDZBQOSA-N
XLogP0.83
TPSA83.61 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500371.44
LogP ≤ 50.83
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one?
The IUPAC name of (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one (CID 125159069) is (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one.
What is the SMILES notation for (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one?
The canonical SMILES for (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one is Cc1cc2n(n1)CCN(C(=O)C[C@H]1C(=O)NCCN1Cc1ccc(C)o1)C2.
What is the InChIKey of (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one?
The InChIKey is CXSCJVVVIOCJAL-KRWDZBQOSA-N. The full InChI is InChI=1S/C19H25N5O3/c1-13-9-15-11-23(7-8-24(15)21-13)18(25)10-17-19(26)20-5-6-22(17)12-16-4-3-14(2)27-16/h3-4,9,17H,5-8,10-12H2,1-2H3,(H,20,26)/t17-/m0/s1.
What are the key properties of (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one?
(3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one has a molecular weight of 371.44 g/mol, XLogP of 0.83, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-[2-(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-oxoethyl]-4-[(5-methylfuran-2-yl)methyl]piperazin-2-one is sourced from PubChem (CID 125159069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).